Tampa, United States
Cognis Group is an international Life Sciences consultancy founded in 2017 with headquarters in the United States. The company specializes in future-proofing company technology innovation pipelines, leveraging their unique methodology called Current Futures to validate tech innovation life cycles over the next two decades. Their offerings include custom consulting services and self-service resource sites such as Pharmalicensing.com and Futureinfocus.com.
Cognis Group's convergence of three decades of experience in Intellectual Property, Strategic Partnering, and Future Trends provides companies and investors with enhanced intelligence validation for informed decision-making. They provide broad access to experts across various science and technology industries, catering to clients ranging from Fortune 500 companies to individual inventors.
Moreover, Cognis Group's global network of partnering connections allows for faster, smarter commercialization of billion-dollar market opportunities. Although the last investment and investors are not disclosed, their focus on Information Technology and the impactful proprietary methodology make Cognis Group an intriguing prospect for potential venture capital interest.
